Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.39 |
| ▸ | SELL | P14151 | 1/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 2/20 | 0.36 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7150962 | 0.76 | CSNK2A1 (0.46) | CSNK2A1SELLSELPSLC22A6SLC22A8 | |
| SCHEMBL317575 | 0.69 | SELL (0.54) | CSNK2A1SELLSELPSLC22A6SLC22A8 | |
| SCHEMBL30443442 | 0.69 | SELL (0.54) | CSNK2A1SELLSELPSLC22A6SLC22A8 | |
| SCHEMBL2059405 | 0.69 | TDP1 (0.53) | CSNK2A1SELLSELPMYCMCL1 | |
| SCHEMBL27710855 | 0.68 | SELL (0.52) | CSNK2A1SELLSELPSLC22A6SLC22A8 | |
| SCHEMBL27711004 | 0.68 | SELL (0.52) | CSNK2A1SELLSELPSLC22A6SLC22A8 | |
| SCHEMBL38623 | 0.68 | SELL (0.64) | CSNK2A1SELLSELPMYCGRM1 | |
| SCHEMBL30589153 | 0.68 | SELL (0.64) | CSNK2A1SELLSELPMYCGRM1 | |
| SCHEMBL12289145 | 0.67 | KDM4E (0.46) | MAPTTDP1TSHRCA12CA1 | |
| SCHEMBL21408388 | 0.67 | CA12 (0.55) | CSNK2A1SELLSELPMYCMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1125908-B1 | New phenolic compounds derived from dialkoxyethanals, their preparation process and their application | CLARIANT SPECIALTY FINE CHEM (FR) | 2008-06-04 | — | — | EP | claimed |
| EP-1125908-B1 | New phenolic compounds derived from dialkoxyethanals, their preparation process and their application | CLARIANT SPECIALTY FINE CHEM (FR) | 2008-06-04 | — | — | EP | disclosed |
| US-6774267-B2 | REACTING A PHENOL COMPOUND WITH AN ALDEHYDE CONTAINING DIALKOXYMETHYL OR 1,3-DIOXOLAN-2-YL GROUP IN PRESENCE OF A BASE | CLARIANT FRANCE (FR) | 2004-08-10 | — | — | US | disclosed |
| US-20010016664-A1 | New phenolic compounds derived from dialkoxyethanals, their preparation process and their application | CLARIANT (FRANCE) S.A. | 2001-08-23 | — | — | US | disclosed |
| EP-1125908-A1 | New phenolic compounds derived from dialkoxyethanals, their preparation process and their application | Clariant (France) S.A. (FR) | 2001-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010016664-A1 | New phenolic compounds derived from dialkoxyethanals, their preparation process and their application | CYC1, CCNY, MT-CO1 | CSNK2A1 732/4885SELL 4715/4885SELP 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.